Eastern Asia vs Israel: Proportion of the target population who received a 3rd dose of
Eastern Asia
10.0%
in 2024
Israel
94.0%
in 2024
Eastern Asia rank
37th
Israel rank
36th
Proportion of the target population who received a 3rd dose of over time
- Eastern Asia
- Israel
How they compare
Israel currently reports 94.0% against 10.0% in Eastern Asia, a difference of 84.0%.
That makes Israel's figure about 9.4 times Eastern Asia's.
Across all 14 years both countries report, Israel has been ahead every year.
Eastern Asia ranks 37th and Israel ranks 36th of 37 groups.
Israel has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Eastern Asia | Israel | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 6.0% | 93.8% | 87.8% | Israel |
| 2020s | 9.4% | 94.2% | 84.8% | Israel |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received a 3rd dose of, Eastern Asia or Israel?
- Israel, at 94.0% against 10.0% in Eastern Asia as of 2024.
- What is the difference in proportion of the target population who received a 3rd dose of between Eastern Asia and Israel?
- 84.0%, with Israel ahead.
- How many years of comparable data are there for Eastern Asia and Israel?
- 14 years are reported by both, from 2011 to 2024.
- How do Eastern Asia and Israel rank globally for proportion of the target population who received a 3rd dose of?
- Eastern Asia ranks 37th and Israel ranks 36th of 37 groups.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.